Top 20 Pulmocide investors
The most complete profiles first. Showing 20 of 20.
Christoph WestphalVerified
Venture Capital, Founder, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 24 more
Verified email available
Eugene HillVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more
Verified email available
Jack KenneyVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Contact details available
Paul LaVioletteVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more
Verified email available
Rich AldrichVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more
Verified email available
Tom FlynnVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Verified email available
David DonabedianVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more
Verified email available
Elizabeth Blake SchwertVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Verified email available
Marian NakadaVerified
Venture Capital, Corporate Venture Capital · United States
Health CareWearablesWellnessWomen FoundedPortfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more
Verified email available
Matthew FoyVerified
Corporate Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Semprus BioSciences, Pulmocide, Syntaxin, CRISPR Therapeutics and 50 more
Verified email available
Mike RossVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Verified email available
Vijay MurthyVerified
Venture Capital, Corporate Venture Capital · United States
Health CareWearablesWellnessWomen FoundedPortfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more
Verified email available
Asish Xavier
Venture Capital, Corporate Venture Capital, Investor · United States
SeedHealth CareWearablesWellnessWomen FoundedPortfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more
Contact details available
Gregory Madden
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more
Contact details available
Houman Ashrafian
Venture Capital, Investor · United Kingdom
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more
Contact details available
Jeanne Bolger
Venture Capital, Corporate Venture Capital, Investor · United Kingdom
Series AHealth CareWearablesWellnessWomen FoundedPortfolio: Catalyst Biosciences, Cardiac Dimensions, CoStim Pharmaceuticals, CoAxia and 58 more
Contact details available
Michael Balmuth
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more
Contact details available
Brent Faduski
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Contact details available
Carl Culicchia
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Contact details available
Lea Hachigian
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Lassen Therapeutics, Pulmocide, Mitobridge, Verastem Oncology and 23 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Pulmocide investors are on Angel Roster?
Angel Roster lists 20 Pulmocide investors. 11 of them (55%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (19), Private Equity Firms (6) and Corporate Venture Capital Firms (5). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Pulmocide investors invest in?
Among those that list a stage, the most common are Seed (10) and Series A (1).
Where are Pulmocide investors based?
Most are based in the United States (17) and the United Kingdom (3).
Which companies have Pulmocide investors backed?
The most-backed portfolio companies among them are Bicycle Therapeutics (16), TopiVert (15), KalVista Pharmaceuticals (15), Thesan Pharmaceuticals (15) and Direct Flow Medical (15).
How do I contact Pulmocide investors?
Create a free Angel Roster account to search and filter all 20, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.